GCT is proud to be conducting the extensive international Phase III clinical study in women’s health. Our full-time in-house teams are responsible for the enrollment of over 1,000 patients in CEE region including Ukraine, Russia, Hungary, Czech Republic and Bulgaria.
Last week Sponsor gathered GCT clinical department members and 39 investigators in Budapest to share experience, different approaches to the treatment across Eastern Europe and report the scientific details of the study.
We believe this project to be of utmost importance for further treatment of patients worldwide, and also a demonstration of GCT capabilities to manage the complicated study and the high quality of our work which maintains the trust of our clients for years.
